All CIRM Grants

Institution Researcher name Grant Type Grant Title Award Value
University of California, Berkeley Jacob Corn Inception - Discovery Stage Research Projects Genome editing for causation and reversion of MPN-associated mutations in human hematopoietic stem cells $235,800
University of California, Los Angeles Arjun Deb Inception - Discovery Stage Research Projects Targeting progenitors in scar tissue to reduce chronic scar burden $230,400
University of California, San Francisco Holger Willenbring Inception - Discovery Stage Research Projects Generation of bile duct-competent transplantable human liver organoids $206,460
Cedars-Sinai Medical Center Linda Cambier Inception - Discovery Stage Research Projects Exosomal Y-RNAs as mediators of bioactivity of cardiac-derived cell therapy $181,063
Cedars-Sinai Medical Center Clive Svendsen Inception - Discovery Stage Research Projects Blood Brain Barrier (BBB)-on-Chip: Development and validation of a novel iPS-based microfluidic model of the human BBB $241,992
Stanford University Phillip Yang Inception - Discovery Stage Research Projects Activation of patient-specific endogenous myocardial repair through the exosomes generated from the hypoxic iPSC-derived cardiomyocytes (iCMs). $234,619
University of California, Los Angeles Bennett Novitch Inception - Discovery Stage Research Projects Organoid Modeling of Human Cortical Microcircuits $208,916
International Society for Experimental Hematology David Traver Conference II International Society for Experimental Hematology, 45th Annual Scientific Meeting $25,000
American Association of Blood Banks Naynesh Kamani Conference II 14th International Cord Blood Symposium: Give Life Twice $15,000
Keystone Symposia on Molecular and Cellular Biology Thale Jarvis Conference II Neurogenesis during Development and in the Adult Brain (joint with Transcriptional and Epigenetic Control in Stem Cells) $35,000
University of California, Irvine LESLIE Thompson Conference II HD-CARE INAUGURAL SYMPOSIUM $1,500
City of Hope, Beckman Research Institute Yanhong Shi Therapeutic Translational Research Projects Process development for establishing an iPSC-based therapeutic candidate for Canavan disease $7,377,384
University of California, Los Angeles Lili Yang Therapeutic Translational Research Projects Stem Cell-Based iNKT Cell Therapy for Cancer $6,956,775
Capricor, Inc Linda Marban Clinical Trial Stage Projects Allogeneic Cardiosphere-Derived Cells for Duchenne Muscular Dystrophy Cardiomyopathy $3,376,259
University of California, San Diego Lawrence Goldstein Therapeutic Translational Research Projects Human Embryonic Stem Cell-Derived Neural Stem Cell Transplants in Amyotrophic Lateral Sclerosis $1,790,000
Semma Therapeutics Felicia Pagliuca Therapeutic Translational Research Projects Personalized Cell Therapy for Diabetes $597,333
University of California, San Francisco Jennifer Puck Late Stage Preclinical Projects Ex Vivo Transduction of the Human Artemis (DCLRE1C) cDNA by Lentiviral Vector AProArt into CD34+ Hematopoietic Cells for Artemis (ART)-Deficient Severe Combined Immunodeficiency (SCID) $4,268,865
University of California, Los Angeles Peter Butler Therapeutic Translational Research Projects Personalized Cell Therapy for Diabetes $1,494,653
Children's Hospital of Los Angeles Tracy Grikscheit Therapeutic Translational Research Projects ASCENT- Advanced Stem Cell Enteric Neuropathy Therapy $7,077,352
University of California, Davis Joseph Anderson Therapeutic Translational Research Projects Overexpression of HexA/HexB by lentivector expression in blood cells to treat Tay-Sachs and Sandhoff disease $883,174
Mosaic Event Management, Inc. Ron Johnson Conference - Manage The 2016 Bridges And SPARK Annual Meetings 2016 CIRM Bridges & SPARK Meetings $205,388
Angiocrine Bioscience, Inc. Paul Finnegan Late Stage Preclinical Projects Development of AB-110: genetically-modified endothelial cells plus expanded cord blood hematopoietic stem cells as a transplantation therapy $3,797,117
University of California, San Diego Catriona Jamieson Conference - The 2016 Alpha Stem Cell Clinic Annual Symposium UCSD Division of Regenerative Medicine and CIRM Alpha Clinics Network Symposium $37,778
San Francisco State University Lily Chen Bridges II CIRM Bridges 2.0: Training the Next Generation of Stem Cell Scientists $2,997,402
San Jose State University Tzvia Abramson Bridges II SCILL- Stem Cell Internships in Laboratory-based Learning $3,036,802
Humboldt State University Jacob Varkey Bridges II CIRM 2.0 Bridges Training Program $2,959,594
Pasadena City College Pamela Eversole-Cire Bridges II Bridges to Stem Cell Research and Therapy at Pasadena City College $2,581,315
City College Of San Francisco Carin Zimmerman Bridges II Stem Cell Training Enhancement Program with a focus on Translational Research $2,146,456
Cal State Univ, Northridge Cindy Malone Bridges II Stem Cell Scientist Training Program $2,760,691
Cal State Univ, San Bernadino Nicole Bournias-Vardiabasis Bridges II Stem Cell Scholars- from Basic Research to Clinical Translation: training a diverse pool of students in the lab, engaging them in patient and healthcare activities, motivating them to educate their immediate community and enabling them for careers in ... $2,667,810
City of Hope, Beckman Research Institute Paul Salvaterra SPARK SPARK Award Program in Stem Cell Biology for California High School Students $309,576
Children's Hospital of Oakland Research Institute Ellen Fung SPARK Leveraging Investment in hiGHschool Training: Summer Program to Accelerate Regenerative medicine Knowledge (LIGHT a SPARK) $236,335
Cedars-Sinai Medical Center Veronica Garcia SPARK Mentored High School Summer Research Program $311,130
Cal State Univ, San Marcos Bianca Mothe Bridges II CIRM Bridges to Stem Cell Research and Therapy Training Grant $3,030,937
University of California, Davis Gerhard Bauer SPARK Internship at a Cutting Edge CIRM-funded Stem Cell Research Facility $388,645
San Diego State University Foundation Ralph Feuer Bridges II Bridges to Stem Cell Research Internship Program $3,041,175
University of California, San Francisco Katherine Nielsen SPARK Developing High School Students' Research Practices and Regenerative Medicine Knowledge through a Summer Intern Program $388,850
Cal State Univ, Channel Island Nitika Parmar Bridges II CIRM Graduate Student Training Grant for the Implementation of a Stem Cell Technology and Lab Management Program: Training in Stem Cell Sciences and Regenerative Medicine $3,030,903
Stanford University Paul Utz SPARK Stem Cell and Regenerative Medicine- Summer Research Internship $392,975
Cal State Univ, Fullerton Nilay Patel Bridges II Bridges to Stem Cell Research, Therapy and Careers: A Talent Development Program for Training Diverse Undergraduates for Careers in Regenerative Medicine $3,045,000
California Institute of Technology Henry Lester SPARK CIRM Early Investigators High School Stem Cell Research Program $214,771
Cal State Univ, Long Beach Lisa Klig Bridges II CIRM Stem Cell Biotechnology Training Program $3,012,342
California Polytechnic State University, San Luis Obispo Trevor Cardinal Bridges II Interdisciplinary Master of Science Program in Regenerative Medicine $2,632,378
Cal State Univ, Sacramento Lisa Hammersley Bridges II Strengthening the Pipeline of Master's-level Scientific and Laboratory Personnel in Stem Cell Research $2,421,720
University of California, San Diego John Ravits Conference II California ALS Research Summit 2016 $11,400
University of California, Los Angeles Donald Kohn Conference II Primary Immune Deficiency Treatment Consortium (PIDTC) Annual Scientific Workshop $29,807
City of Hope, Beckman Research Institute Fouad Kandeel Conference II 2016 Rachmiel Levine-Arthur Riggs Diabetes Research Symposium $10,000
Gordon Research Conferences Ophir Klein Conference II 2016 Gordon Research Conference on Craniofacial Morphogenesis and Tissue Regeneration $5,000
Stanford University Joseph Wu Conference II Drug Discovery & Stem Cell Models for Cardiovascular Disease Conference $7,500
ImmunoCellular Therapeutics Anthony Gringeri Clinical Trial Stage Projects A Phase III randomized double-blind, controlled study of ICT 107 with maintenance temozolomide (TMZ) in newly diagnosed glioblastoma following resection and concomitant TMZ chemoradiotherapy $5,391,016
University of California, Irvine Sidney Golub Conference II Human Research In Times of Controversy: From Stem Cells To Fetal Tissue $13,562
Sanford Consortium for Regenerative Medicine Edward Holmes Conference II Stem Cell Meeting on the Mesa $50,000
Alliance Forum Foundation George Hara Conference II 2015 World Alliance Forum in San Francisco (2015 WAFSF) "Regenerative Medicine: Let's Talk Business!" $10,000
Calibr Peter Schultz Late Stage Preclinical Projects Development of a Chondrogenic Drug Candidate Targeting Resident Mesenchymal Stem Cells for the Treatment of Osteoarthritis $1,667,832
University of California, Davis Mehrdad Abedi Clinical Trial Stage Projects Stem Cell Gene Therapy for HIV Mediated by Lentivector Transduced, Pre-selected CD34+ Cells in AIDS lymphoma patients $8,414,265
University of California, Los Angeles Donald Kohn Clinical Trial Stage Projects A Phase I/II, Non Randomized, Multicenter, Open-Label Study of G1XCGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease $7,083,364
Cedars-Sinai Medical Center Shaomei Wang Late Stage Preclinical Projects IND-enabling study of subretinal delivery of human neural progenitor cells for the treatment of retinitis pigmentosa $4,954,514
Caladrius Biosciences Robert Dillman Clinical Trial Stage Projects Tumor stem cell-targeted immunotherapy for metastatic melanoma –a randomized phase 3 clinical trial. $3,000,000
Stanford University Matthew Porteus Preclinical Development Awards Pre-clinical development of gene correction therapy of hematopoietic stem cells for SCID-X1 $874,877
Salk Institute for Biological Studies David Schubert Preclinical Development Awards Human Stem-Cell Based Development of a Potent Alzheimer’s Drug Candidate $1,664,885
University of California, Irvine Leslie Thompson Preclinical Development Awards A hNSC Development Candidate for Huntington’s Disease $4,951,623
Calibr Peter Schultz Preclinical Development Awards Development of a Chondrogenic Drug Candidate Targeting Cartilage-residing Mesenchymal Stem Cells for the Treatment of Osteoarthritis $2,306,703
University of California, Davis Diana Farmer Preclinical Development Awards Placental Stem Cells for the In Utero Treatment of Spina Bifida $2,182,146
University of California, Davis Roslyn Isseroff Preclinical Development Awards Scaffold for dermal regeneration containing pre-conditioned mesenchymal stem cells to heal chronic diabetic wounds $4,620,144
Scripps Health Darryl D'Lima Preclinical Development Awards Embryonic Stem Cell-Derived Chondroprogenitor Cells to Repair Osteochondral Defects $7,660,211
Vitalant Research Institute Shibani Pati Conference Cellular Therapies in Trauma and Critical Care Medicine: Forging New Frontiers $40,000
University of Southern California Qing Liu-Michael Conference USC/UCSF/UCLA Tri-Institutional Stem Cell Retreat $5,000
Ocular Research Symposia Foundation, Inc. Gerald Chader Conference SIGHT RESTORATION THROUGH STEM CELL THERAPY $20,000
Stanford University Joseph Wu Conference Cardiovascular Tissue Engineering Symposium $25,000
University of California, Davis Randi Hagerman Conference Pathways of Neurodevelopmental Disorders (C8) $29,939
Stanford University Sarah Heilshorn Tools and Technologies III Injectable Hydrogels for the Delivery, Maturation, and Engraftment of Clinically Relevant Numbers of Human Induced Pluripotent Stem Cell-Derived Neural Progenitors to the Central Nervous System $1,347,767
University of California, Irvine Mathew Blurton-Jones Tools and Technologies III Optimizing the differentiation and expansion of microglial progenitors from human pluripotent stem cells for the study and treatment of neurological disease. $1,147,596
Stanford University Irving Weissman Tools and Technologies III Identification and isolation of transplantable human hematopoietic stem cells from pluripotent cell lines; two steps from primitive hematopoiesis to transplantable definitive cells, and non-toxic conditioning of hosts for hematopoeitic stem cell transp... $1,271,952
City of Hope, Beckman Research Institute Joseph Gold Tools and Technologies III Development of a scalable, practical, and transferable GMP-compliant suspension culture-based differentiation process for cardiomyocyte production from human embryonic stem cells. $891,518
University of Southern California Paula Cannon Tools and Technologies III Site-specific gene editing in hematopoietic stem cells as an anti-HIV therapy $1,495,665
University of Southern California Toshio Miki Tools and Technologies III Development of a clinical-grade extracorporeal liver support system using human induced pluripotent stem cell-derived hepatic cells $1,257,011
University of Southern California Qilong Ying Tools and Technologies III Embryonic stem cell-based generation of rat models for assessing human cellular therapies $1,326,979
University of California, Los Angeles Hanna Mikkola Tools and Technologies III A suite of engineered human pluripotent stem cell lines to facilitate the generation of hematopoietic stem cells $1,382,400
University of California, San Francisco Andrew Leavitt Tools and Technologies III Small molecule tools and scale-up technologies to expand human umbilical cord blood stem and progenitor cells for clinical and research use $1,416,600
Stanford University Anthony Oro Tools and Technologies III A Chromatin Context Tool for Predicting iPS Lineage Predisposition and Tissue Graftability $1,391,125
Stanford University Joseph Wu Tools and Technologies III Macaca mulatta as advanced model for predictive preclinical testing of engineered cardiac autografts and allografts $1,689,744
University of California, San Diego Shaochen Chen Tools and Technologies III Development of 3D Bioprinting Techniques using Human Embryonic Stem Cells Derived Cardiomyocytes for Cardiac Tissue Engineering $1,368,264
University of California, Los Angeles Carla Koehler Tools and Technologies III A small molecule tool for reducing the malignant potential in reprogramming human iPSCs and ESCs $1,283,900
University of California, Berkeley David Schaffer Tools and Technologies III Engineered Biomaterials for Scalable Manufacturing and High Viability Implantation of hPSC-Derived Cells to Treat Neurodegenerative Disease $1,239,276
University of California, San Diego Shyni Varghese Tools and Technologies III Technologies to improve in vivo function of transplanted stem cells $1,373,683
University of California, Los Angeles Leif Havton Tools and Technologies III Development of a Relevant Pre-Clinical Animal Model as a Tool to Evaluate Human Stem Cell-Derived Replacement Therapies for Motor Neuron Injuries and Degenerative Diseases $1,308,711
Scripps Research Institute Jeanne Loring Tools and Technologies III User-friendly predictive molecular diagnostic assays for quality control of stem cell derivatives for transplantation and drug discovery $1,728,390
University of California, Los Angeles James Dunn Tools and Technologies III Skin-derived precursor cells for the treatment of enteric neuromuscular dysfunction $1,044,423
Stanford University James Dunn Tools and Technologies III Skin-derived precursor cells for the treatment of enteric neuromuscular dysfunction $772,098
University of California, Davis J. Leach Tools and Technologies III Multi-modal technology for non-destructive characterization of bioengineered tissues $1,574,151
University of California, Davis Laura Marcu Tools and Technologies III Multimodal platform combining optical and ultrasonic technologies for in vivo nondestructive evaluation of engineered vascular tissue constructs $1,834,474
Stanford University Fan Yang Tools and Technologies III Injectable Macroporous Matrices to Enhance Stem Cell Engraftment and Survival $1,438,200
Gordon Research Conferences Leonard Zon Conference 2015 Gordon Research Conference: Stem Cells & Cancer $20,000
City of Hope, Beckman Research Institute Fouad Kandeel Conference 15th Annual Rachmiel Levine Diabetes and Obesity Symposium $20,000
Gladstone Institutes, J. David Steven Finkbeiner Conference THE 5TH ANNUAL CALIFORNIA ALS PAC10 AND RESEARCH NETWORK MEETING $9,529
University of California, San Diego Catriona Jamieson Alpha Stem Cell Clinics Alpha Stem Cell Clinic for the Development of Regenerative Therapies $7,999,137
University of California, Los Angeles John Adams Alpha Stem Cell Clinics UCLA-UCI Alpha Stem Cell Clinic (ASCC) Consortium $8,000,000
City of Hope, Beckman Research Institute John Zaia Alpha Stem Cell Clinics The Innovation-Alpha Clinic for Cellular Therapies (I-ACT) – A Program for the Development and Delivery of Innovative Cell-based Treatments and Cures for Life-threatening Diseases. $8,000,000
University of California, Davis Alice Tarantal Conference 13th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases $10,000
ViaCyte, Inc. Howard Foyt Accelerated Development Pathway I Clinical Development of a Cell Therapy for Diabetes $8,783,852

Pages

Icon for xls export